LETTER TO THE EDITOR
Multiple bullous pilomatricomas in a patient with Rubinstein–Taybi syndrome
Lisa Minai,
Lisa Minai
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Hideaki Yagasaki,
Hideaki Yagasaki
Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Youichi Ogawa,
Corresponding Author
Youichi Ogawa
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Correspondence
Youichi Ogawa, M.D., Ph.D., Department of Dermatology, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan.
Email: [email protected]
Search for more papers by this author Nobuhiro Deguchi,
Nobuhiro Deguchi
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Hiroshi Mitsui,
Hiroshi Mitsui
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Shinji Shimada,
Shinji Shimada
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Tatsuyoshi Kawamura,
Tatsuyoshi Kawamura
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author
Lisa Minai,
Lisa Minai
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Hideaki Yagasaki,
Hideaki Yagasaki
Department of Pediatrics, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Youichi Ogawa,
Corresponding Author
Youichi Ogawa
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Correspondence
Youichi Ogawa, M.D., Ph.D., Department of Dermatology, Faculty of Medicine, University of Yamanashi, 1110 Shimokato, Chuo, Yamanashi 409-3898, Japan.
Email: [email protected]
Search for more papers by this author Nobuhiro Deguchi,
Nobuhiro Deguchi
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Hiroshi Mitsui,
Hiroshi Mitsui
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Shinji Shimada,
Shinji Shimada
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author Tatsuyoshi Kawamura,
Tatsuyoshi Kawamura
Department of Dermatology, Faculty of Medicine, University of Yamanashi, Yamanashi, Japan
Search for more papers by this author
First published: 12 June 2021
No abstract is available for this article.
CONFLICT OF INTEREST
Not declared.
REFERENCES
- 1Hennekam RC. Rubinstein-Taybi syndrome. Eur J Hum Genet. 2006; 14(9): 981–5.
- 2Petrif F, Giles RH, Dauwerse HG, Saris JJ, Hennekam RCM, Masuno M, et al. Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP. Nature. 1995; 376(6538): 348–51.
- 3Roelfsema JH, White SJ, Ariyürek Y, Bartholdi D, Niedrist D, Papadia F, et al. Genetic heterogeneity in Rubinstein-Taybi syndrome: mutations in both the CBP and EP300 genes cause disease. Am J Hum Genet. 2005; 76(4): 572–80.
- 4Boot MV, van Belzen MJ, Overbeek LI, Hijmering N, Mendeville M, Waisfisz Q, et al. Benign and malignant tumors in Rubinstein-Taybi syndrome. Am J Med Genet A. 2018; 176(3): 597–608.
- 5Ciriacks K, Knabel D, Waite MB. Syndromes associated with multiple pilomatricomas: When should clinicians be concerned? Pediatr Dermatol. 2020; 37(1): 9–17.
